Profarma Distribuidora de Produtos Farmacêuticos Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Profarma Distribuidora de Produtos Farmacêuticos.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 27.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 02
Shareholders Will Be Pleased With The Quality of Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Earnings
Aug 14Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) 28% Price Boost Is Out Of Tune With Earnings
Mar 01These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Feb 21Returns On Capital Are Showing Encouraging Signs At Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3)
Nov 04Investors Will Want Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Growth In ROCE To Persist
Aug 03These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Jun 08These 4 Measures Indicate That Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Using Debt Extensively
Sep 26Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Shares Fly 26% But Investors Aren't Buying For Growth
Jan 01Here's Why Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Is Weighed Down By Its Debt Load
May 28Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Might Have The Makings Of A Multi-Bagger
May 07How Much Of Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3) Do Institutions Own?
Mar 10Are Profarma Distribuidora de Produtos Farmacêuticos' (BVMF:PFRM3) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02
Is Profarma Distribuidora de Produtos Farmacêuticos (BVMF:PFRM3) Using Too Much Debt?
Jan 05What Type Of Shareholders Make Up Profarma Distribuidora de Produtos Farmacêuticos S.A.'s (BVMF:PFRM3) Share Registry?
Dec 10In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Profarma Distribuidora de Produtos Farmacêuticos has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 9,038 | 91 | 468 | 571 | N/A |
| 3/31/2024 | 8,889 | 77 | 234 | 323 | N/A |
| 12/31/2023 | 8,662 | 70 | 179 | 261 | N/A |
| 9/30/2023 | 8,550 | 47 | 310 | 385 | N/A |
| 6/30/2023 | 8,291 | 31 | 221 | 292 | N/A |
| 3/31/2023 | 8,087 | 82 | 279 | 349 | N/A |
| 12/31/2022 | 7,816 | 81 | 56 | 126 | N/A |
| 9/30/2022 | 7,435 | 87 | 58 | 119 | N/A |
| 6/30/2022 | 7,031 | 96 | -117 | -50 | N/A |
| 3/31/2022 | 6,661 | 63 | -61 | 20 | N/A |
| 12/31/2021 | 6,413 | 78 | 25 | 108 | N/A |
| 9/30/2021 | 6,199 | 95 | -161 | -82 | N/A |
| 6/30/2021 | 5,891 | 99 | -336 | -267 | N/A |
| 3/31/2021 | 5,579 | 60 | -33 | 18 | N/A |
| 12/31/2020 | 5,481 | 52 | -6 | 39 | N/A |
| 9/30/2020 | 5,281 | 44 | 76 | 114 | N/A |
| 6/30/2020 | 5,218 | 16 | 119 | 150 | N/A |
| 3/31/2020 | 5,104 | 21 | 42 | 69 | N/A |
| 12/31/2019 | 4,801 | 12 | 100 | 128 | N/A |
| 9/30/2019 | 4,677 | -5 | 60 | 85 | N/A |
| 6/30/2019 | 4,513 | -13 | -18 | 5 | N/A |
| 3/31/2019 | 4,388 | -12 | -86 | -65 | N/A |
| 12/31/2018 | 4,271 | -10 | -71 | -56 | N/A |
| 9/30/2018 | 4,066 | -37 | -100 | -81 | N/A |
| 6/30/2018 | 4,009 | -65 | -47 | -22 | N/A |
| 3/31/2018 | 4,046 | -91 | N/A | -61 | N/A |
| 12/31/2017 | 4,101 | -113 | N/A | -52 | N/A |
| 9/30/2017 | 4,223 | -126 | N/A | 7 | N/A |
| 6/30/2017 | 4,195 | -100 | N/A | 54 | N/A |
| 3/31/2017 | 4,149 | -67 | N/A | -63 | N/A |
| 12/31/2016 | 4,085 | -49 | N/A | -107 | N/A |
| 9/30/2016 | 3,858 | -18 | N/A | -84 | N/A |
| 6/30/2016 | 3,780 | -14 | N/A | -95 | N/A |
| 3/31/2016 | 3,619 | -23 | N/A | -14 | N/A |
| 12/31/2015 | 3,465 | -21 | N/A | 59 | N/A |
| 9/30/2015 | 3,471 | -34 | N/A | 1 | N/A |
| 6/30/2015 | 3,392 | -48 | N/A | -82 | N/A |
| 3/31/2015 | 3,430 | -46 | N/A | 11 | N/A |
| 12/31/2014 | 3,449 | -52 | N/A | 59 | N/A |
| 9/30/2014 | 3,439 | -37 | N/A | 52 | N/A |
| 6/30/2014 | 3,455 | -11 | N/A | 73 | N/A |
| 3/31/2014 | 3,456 | 0 | N/A | 53 | N/A |
| 12/31/2013 | 3,470 | 20 | N/A | -90 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if PFRM3's forecast earnings growth is above the savings rate (10.1%).
Earnings vs Market: Insufficient data to determine if PFRM3's earnings are forecast to grow faster than the BR market
High Growth Earnings: Insufficient data to determine if PFRM3's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if PFRM3's revenue is forecast to grow faster than the BR market.
High Growth Revenue: Insufficient data to determine if PFRM3's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PFRM3's Return on Equity is forecast to be high in 3 years time